Table 3. Summary of small molecule inhibitors of amyloid oligomers for the treatment of Alzheimer's disease.

Name	Targets	Effects	Ref
2-Amino-4-chlorophenol	Blocks Aβ oligomerization and fibrillization	Blocks neurotoxicity	259
4-Aminophenol	Blocks Aβ oligomerization and fibrillization	Blocks neurotoxicity	259
4-Aminoanisole	Blocks Aβ oligomerization and fibrillization	Blocks neurotoxicity	259
3,4-Dihydroxybenzoic acid	Blocks Aβ oligomerization and fibrillization	Blocks neurotoxicity	259
2-Hydroxy-3-ethoxy benzoaldehyde	Blocks Aβ oligomerization and fibrillization	Blocks neurotoxicity	259
Resveratrol	Remodels soluble oligomers and amyloid fibrils into nontoxic species	Attenuates cognitive deterioration	351
NQTrp	Inhibits the fibrillization of amyloidogenic proteins	Reduces Aβ aggregation	269,270
ClNQTrp	Inhibits the fibrillization of amyloidogenic proteins	Reduces Aβ aggregation	269,270
Coumarin	Inhibits Aβ aggregation	Prevents cognitive decline	266
Furosemide	Inhibits Aβ oligomerization	Increases the life span	273
D737	Inhibits Aβ formation	Prevents toxicity and ROS accumulation	274